Dr Eshamumerene Esin, MD | |
3707 Largent Way Nw, Marietta, GA 30064-5981 | |
(678) 581-5729 | |
(678) 581-5835 |
Full Name | Dr Eshamumerene Esin |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 21 Years |
Location | 3707 Largent Way Nw, Marietta, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538459292 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD20140703 (New Mexico) | Secondary |
207Q00000X | Family Medicine | 77256 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wellstar Kennestone Hospital | Marietta, GA | Hospital |
Wellstar Cobb Hospital | Austell, GA | Hospital |
Wellstar Paulding Hospital | Hiram, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
Blocking a specific protein complex prevents the formation of tumors in mice genetically predisposed to develop prostate cancer.
ImmunoGen, Inc. announced today that it has entered into a collaboration agreement with Novartis to discover and develop targeted anticancer therapeutics using antibodies to several antigen targets to be named by Novartis.
Researchers studied convalescent plasma from recovered coronavirus disease 2019 (COVID-19) patients, with samples collected up to 34 weeks after recovery. They found IgG antibodies gradually declined with a median half-life of about 60 days.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.
› Verified 2 days ago
Entity Name | Wellstar Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Blocking a specific protein complex prevents the formation of tumors in mice genetically predisposed to develop prostate cancer.
ImmunoGen, Inc. announced today that it has entered into a collaboration agreement with Novartis to discover and develop targeted anticancer therapeutics using antibodies to several antigen targets to be named by Novartis.
Researchers studied convalescent plasma from recovered coronavirus disease 2019 (COVID-19) patients, with samples collected up to 34 weeks after recovery. They found IgG antibodies gradually declined with a median half-life of about 60 days.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Eshamumerene Esin, MD 4815 Alameda Ave, El Paso, TX 79905-2705 Ph: (915) 544-1200 | Dr Eshamumerene Esin, MD 3707 Largent Way Nw, Marietta, GA 30064-5981 Ph: (678) 581-5729 |
News Archive
Blocking a specific protein complex prevents the formation of tumors in mice genetically predisposed to develop prostate cancer.
ImmunoGen, Inc. announced today that it has entered into a collaboration agreement with Novartis to discover and develop targeted anticancer therapeutics using antibodies to several antigen targets to be named by Novartis.
Researchers studied convalescent plasma from recovered coronavirus disease 2019 (COVID-19) patients, with samples collected up to 34 weeks after recovery. They found IgG antibodies gradually declined with a median half-life of about 60 days.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies to enhance vaccine production yields, and other innovative biologics, announced today that the European Patent Office recently granted patent protection for the company's proprietary VIRUSMAX technology, which is designed to increase influenza vaccine yields and has demonstrated an average yield increase of at least two-fold over current vaccine production methods.
› Verified 2 days ago
Dr. Yen-i Grace Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 Johnson Ferry Rd, Marietta, GA 30068 Phone: 770-579-7900 Fax: 770-579-7942 | |
Neety Patel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3707 Largent Way Nw, Marietta, GA 30064 Phone: 678-581-5830 Fax: 678-581-5835 | |
Jamin Graham, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 677 Church St Ne, Marietta, GA 30060 Phone: 770-793-5000 | |
Dr. Philip Batista, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Johnson Ferry Rd, Marietta, GA 30068 Phone: 770-579-7900 Fax: 770-579-7932 | |
Dr. Harvey David Braunfeld, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 299 Pat Mell Rd Se, Marietta, GA 30060 Phone: 770-432-5500 Fax: 770-431-8363 | |
William Edward Snell, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 880 Canton Rd Ne, Suite 300, Marietta, GA 30060 Phone: 770-590-0585 Fax: 770-428-4087 | |
Dr. Miles Eli Brett, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2520 Windy Hill Rd Se, Suite 301, Marietta, GA 30067 Phone: 770-952-1032 Fax: 770-952-8579 |